On this line, treatment of CLL cells with macitentan was able to interfere with another crucial chemokine CXCL12, secreted by stromal cells and well known to be essential for CLL migration inside tissues (Figure 5B). This evidence concerns the gene CXCL12 and B-cell chronic lymphocytic leukemia.